Skip to main content

Table 4 Cost results (USD 2015)

From: Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

  Ceftolozane/tazobactam Piperacillin/tazobactam Incremental
Ceftolozane/tazobactam - Piperacillin/tazobactam
Hospital costs per patient $6996 $7429 -$433
Drug costs per patient $766 $155 $612
Lifetime health care expenditure per patient $28,651 $28,444 $207